 | • レポートコード：MRC23Q36093 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のIn VitroADMEサービス市場について調査・分析し、世界のIn VitroADMEサービス市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（低分子、生物製剤）、用途別セグメント分析（バイオ医薬品企業、政府＆学術機関、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Charles River、Labcorp、Envigo、Curia、Evotec、Bioduro-Sundia、Lonza、WuXi AppTec、IQVIA、Tecan Group、Pharmaron、Shanghai Medicilon、ChemPartner、Joinn Laboratories、RTI International、Eurofins Scientific、Aragen Life Sciences、Sai Life Sciencesなどが含まれています。世界のIn VitroADMEサービス市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、In VitroADMEサービス市場規模を推定する際に考慮しました。本レポートは、In VitroADMEサービスの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、In VitroADMEサービスに関するビジネス上の意思決定に役立てることを目的としています。 ・In VitroADMEサービス市場の概要 - In VitroADMEサービスのタイプ別セグメント - 世界のIn VitroADMEサービス市場規模：タイプ別分析（低分子、生物製剤） - In VitroADMEサービスの用途別セグメント - 世界のIn VitroADMEサービス市場規模：用途別分析（バイオ医薬品企業、政府＆学術機関、その他） - 世界のIn VitroADMEサービス市場規模予測（2018年-2029年） ・In VitroADMEサービス市場の成長トレンド - In VitroADMEサービスの地域別市場規模（2018年-2029年） - In VitroADMEサービス市場ダイナミクス - In VitroADMEサービスの業界動向 - In VitroADMEサービス市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：低分子、生物製剤 - 世界のIn VitroADMEサービスのタイプ別市場規模（2018年-2023年） - 世界のIn VitroADMEサービスのタイプ別市場規模（2024年-2029年） ・用途別セグメント：バイオ医薬品企業、政府＆学術機関、その他 - 世界のIn VitroADMEサービスの用途別市場規模（2018年-2023年） - 世界のIn VitroADMEサービスの用途別市場規模（2024年-2029年） ・In VitroADMEサービスの地域別市場規模 - 北米のIn VitroADMEサービス市場規模（2018年-2029年） - アメリカのIn VitroADMEサービス市場規模（2018年-2029年） - ヨーロッパのIn VitroADMEサービス市場規模（2018年-2029年） - アジア太平洋のIn VitroADMEサービス市場規模（2018年-2029年） - 中国のIn VitroADMEサービス市場規模（2018年-2029年） - 日本のIn VitroADMEサービス市場規模（2018年-2029年） - 韓国のIn VitroADMEサービス市場規模（2018年-2029年） - インドのIn VitroADMEサービス市場規模（2018年-2029年） - オーストラリアのIn VitroADMEサービス市場規模（2018年-2029年） - 中南米のIn VitroADMEサービス市場規模（2018年-2029年） - 中東・アフリカのIn VitroADMEサービス市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Charles River、Labcorp、Envigo、Curia、Evotec、Bioduro-Sundia、Lonza、WuXi AppTec、IQVIA、Tecan Group、Pharmaron、Shanghai Medicilon、ChemPartner、Joinn Laboratories、RTI International、Eurofins Scientific、Aragen Life Sciences、Sai Life Sciences ・アナリストの観点/結論 ・調査方法とデータソース |
In the early stages of drug discovery, it is important to understand the key physicochemical properties and structural motifs that drive the efficacy and safety profile of a compound candidate. In vitro ADME is used to identify the attributes of absorption, distribution, metabolism, and excretion. ADME assays are critical in gaining insight into metabolism and potential drug interactions.
Highlights
The global In – Vitro ADME Services market was valued at US$ 873.3 million in 2022 and is anticipated to reach US$ 1456.6 million by 2029, witnessing a CAGR of 8.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global In – Vitro ADME Services companies include Charles River, Labcorp, Envigo, Curia, Evotec, etc. Global top 3 companies hold a share over 32%. North America is the largest market, with a share about 47%, followed by Europe and Asia-Pacific.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In – Vitro ADME Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In – Vitro ADME Services.
The In – Vitro ADME Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In – Vitro ADME Services market comprehensively. Regional market sizes, concerning products by type, by end user, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In – Vitro ADME Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by end user, and by regions.
By Company
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Segment by Type
Small Molecules
Biologics
Segment by End User
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, end user, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In – Vitro ADME Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by end user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In – Vitro ADME Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by End User
1.3.1 Global In – Vitro ADME Services Market Growth by End User: 2018 VS 2022 VS 2029
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In – Vitro ADME Services Market Perspective (2018-2029)
2.2 In – Vitro ADME Services Growth Trends by Region
2.2.1 Global In – Vitro ADME Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 In – Vitro ADME Services Historic Market Size by Region (2018-2023)
2.2.3 In – Vitro ADME Services Forecasted Market Size by Region (2024-2029)
2.3 In – Vitro ADME Services Market Dynamics
2.3.1 In – Vitro ADME Services Industry Trends
2.3.2 In – Vitro ADME Services Market Drivers
2.3.3 In – Vitro ADME Services Market Challenges
2.3.4 In – Vitro ADME Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In – Vitro ADME Services Players by Revenue
3.1.1 Global Top In – Vitro ADME Services Players by Revenue (2018-2023)
3.1.2 Global In – Vitro ADME Services Revenue Market Share by Players (2018-2023)
3.2 Global In – Vitro ADME Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In – Vitro ADME Services Revenue
3.4 Global In – Vitro ADME Services Market Concentration Ratio
3.4.1 Global In – Vitro ADME Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In – Vitro ADME Services Revenue in 2022
3.5 In – Vitro ADME Services Key Players Head office and Area Served
3.6 Key Players In – Vitro ADME Services Product Solution and Service
3.7 Date of Enter into In – Vitro ADME Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In – Vitro ADME Services Breakdown Data by Type
4.1 Global In – Vitro ADME Services Historic Market Size by Type (2018-2023)
4.2 Global In – Vitro ADME Services Forecasted Market Size by Type (2024-2029)
5 In – Vitro ADME Services Breakdown Data by End User
5.1 Global In – Vitro ADME Services Historic Market Size by End User (2018-2023)
5.2 Global In – Vitro ADME Services Forecasted Market Size by End User (2024-2029)
6 North America
6.1 North America In – Vitro ADME Services Market Size (2018-2029)
6.2 North America In – Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America In – Vitro ADME Services Market Size by Country (2018-2023)
6.4 North America In – Vitro ADME Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In – Vitro ADME Services Market Size (2018-2029)
7.2 Europe In – Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe In – Vitro ADME Services Market Size by Country (2018-2023)
7.4 Europe In – Vitro ADME Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In – Vitro ADME Services Market Size (2018-2029)
8.2 Asia-Pacific In – Vitro ADME Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific In – Vitro ADME Services Market Size by Region (2018-2023)
8.4 Asia-Pacific In – Vitro ADME Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In – Vitro ADME Services Market Size (2018-2029)
9.2 Latin America In – Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America In – Vitro ADME Services Market Size by Country (2018-2023)
9.4 Latin America In – Vitro ADME Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In – Vitro ADME Services Market Size (2018-2029)
10.2 Middle East & Africa In – Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa In – Vitro ADME Services Market Size by Country (2018-2023)
10.4 Middle East & Africa In – Vitro ADME Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River In – Vitro ADME Services Introduction
11.1.4 Charles River Revenue in In – Vitro ADME Services Business (2018-2023)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp In – Vitro ADME Services Introduction
11.2.4 Labcorp Revenue in In – Vitro ADME Services Business (2018-2023)
11.2.5 Labcorp Recent Development
11.3 Envigo
11.3.1 Envigo Company Detail
11.3.2 Envigo Business Overview
11.3.3 Envigo In – Vitro ADME Services Introduction
11.3.4 Envigo Revenue in In – Vitro ADME Services Business (2018-2023)
11.3.5 Envigo Recent Development
11.4 Curia
11.4.1 Curia Company Detail
11.4.2 Curia Business Overview
11.4.3 Curia In – Vitro ADME Services Introduction
11.4.4 Curia Revenue in In – Vitro ADME Services Business (2018-2023)
11.4.5 Curia Recent Development
11.5 Evotec
11.5.1 Evotec Company Detail
11.5.2 Evotec Business Overview
11.5.3 Evotec In – Vitro ADME Services Introduction
11.5.4 Evotec Revenue in In – Vitro ADME Services Business (2018-2023)
11.5.5 Evotec Recent Development
11.6 Bioduro-Sundia
11.6.1 Bioduro-Sundia Company Detail
11.6.2 Bioduro-Sundia Business Overview
11.6.3 Bioduro-Sundia In – Vitro ADME Services Introduction
11.6.4 Bioduro-Sundia Revenue in In – Vitro ADME Services Business (2018-2023)
11.6.5 Bioduro-Sundia Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza In – Vitro ADME Services Introduction
11.7.4 Lonza Revenue in In – Vitro ADME Services Business (2018-2023)
11.7.5 Lonza Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Detail
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec In – Vitro ADME Services Introduction
11.8.4 WuXi AppTec Revenue in In – Vitro ADME Services Business (2018-2023)
11.8.5 WuXi AppTec Recent Development
11.9 IQVIA
11.9.1 IQVIA Company Detail
11.9.2 IQVIA Business Overview
11.9.3 IQVIA In – Vitro ADME Services Introduction
11.9.4 IQVIA Revenue in In – Vitro ADME Services Business (2018-2023)
11.9.5 IQVIA Recent Development
11.10 Tecan Group
11.10.1 Tecan Group Company Detail
11.10.2 Tecan Group Business Overview
11.10.3 Tecan Group In – Vitro ADME Services Introduction
11.10.4 Tecan Group Revenue in In – Vitro ADME Services Business (2018-2023)
11.10.5 Tecan Group Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Detail
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron In – Vitro ADME Services Introduction
11.11.4 Pharmaron Revenue in In – Vitro ADME Services Business (2018-2023)
11.11.5 Pharmaron Recent Development
11.12 Shanghai Medicilon
11.12.1 Shanghai Medicilon Company Detail
11.12.2 Shanghai Medicilon Business Overview
11.12.3 Shanghai Medicilon In – Vitro ADME Services Introduction
11.12.4 Shanghai Medicilon Revenue in In – Vitro ADME Services Business (2018-2023)
11.12.5 Shanghai Medicilon Recent Development
11.13 ChemPartner
11.13.1 ChemPartner Company Detail
11.13.2 ChemPartner Business Overview
11.13.3 ChemPartner In – Vitro ADME Services Introduction
11.13.4 ChemPartner Revenue in In – Vitro ADME Services Business (2018-2023)
11.13.5 ChemPartner Recent Development
11.14 Joinn Laboratories
11.14.1 Joinn Laboratories Company Detail
11.14.2 Joinn Laboratories Business Overview
11.14.3 Joinn Laboratories In – Vitro ADME Services Introduction
11.14.4 Joinn Laboratories Revenue in In – Vitro ADME Services Business (2018-2023)
11.14.5 Joinn Laboratories Recent Development
11.15 RTI International
11.15.1 RTI International Company Detail
11.15.2 RTI International Business Overview
11.15.3 RTI International In – Vitro ADME Services Introduction
11.15.4 RTI International Revenue in In – Vitro ADME Services Business (2018-2023)
11.15.5 RTI International Recent Development
11.16 Eurofins Scientific
11.16.1 Eurofins Scientific Company Detail
11.16.2 Eurofins Scientific Business Overview
11.16.3 Eurofins Scientific In – Vitro ADME Services Introduction
11.16.4 Eurofins Scientific Revenue in In – Vitro ADME Services Business (2018-2023)
11.16.5 Eurofins Scientific Recent Development
11.17 Aragen Life Sciences
11.17.1 Aragen Life Sciences Company Detail
11.17.2 Aragen Life Sciences Business Overview
11.17.3 Aragen Life Sciences In – Vitro ADME Services Introduction
11.17.4 Aragen Life Sciences Revenue in In – Vitro ADME Services Business (2018-2023)
11.17.5 Aragen Life Sciences Recent Development
11.18 Sai Life Sciences
11.18.1 Sai Life Sciences Company Detail
11.18.2 Sai Life Sciences Business Overview
11.18.3 Sai Life Sciences In – Vitro ADME Services Introduction
11.18.4 Sai Life Sciences Revenue in In – Vitro ADME Services Business (2018-2023)
11.18.5 Sai Life Sciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details